English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/99915
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 0 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar bibText (RIS)Exportar csv (RIS)
Título

Decreased cerebrospinal fluid levels of L-carnitine in non-apolipoprotein E4 carriers at early stages of Alzheimer's disease

Autor Lodeiro, María; Ibáñez, Clara ; Cifuentes, Alejandro ; Simó, Carolina ; Cedazo-Mínguez, Ángel
Palabras clave APOE4
Cerebrospinal fluid
Alzheimer's disease
Biomarkers
L-carnitine
Fecha de publicación 2014
EditorIOS Press
Citación Journal of Alzheimer's Disease 41(1): 223-232 (2014)
ResumenIncreasing evidence suggest that Alzheimer's disease (AD) is a heterogeneous disorder that includes several subtypes with different etiology and progression. Cerebrospinal fluid (CSF) is being used to find new biomarkers reflecting the complexity of the pathological pathways within this disease. We used CSF and clinical data from patients to investigate the status of asymmetric dimethyl-L-arginine, creatine, suberylglycine, and L-carnitine along AD progression. These molecules play important roles in mitochondrial function and dysfunction in mitochondrial metabolism are involved in AD pathology. We found that non-APOE4 carriers show lower levels of L-carnitine in CSF early in AD. L-carnitine levels correlate with amyloid-β (Aβ) levels and Mini-Mental State Examination score, but do not add to the specificity or sensitivity of the classical AD CSF biomarkers, Aβ42, phospho-tau, and total-tau. Our results suggest APOE genotype-dependent differences in L-carnitine synthesis or metabolism along AD, and insinuate that L-carnitine treatments would be more beneficial for AD patients not carrying the APOE4 isoform. © 2014 - IOS Press and the authors. All rights reserved.
Versión del editorhttp://dx.doi.org/10.3233/JAD-132063
URI http://hdl.handle.net/10261/99915
DOI10.3233/JAD-132063
Identificadoresdoi: 10.3233/JAD-132063
e-issn: 1875-8908
issn: 1387-2877
Aparece en las colecciones: (CIAL) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Decreased CSF levelsE4.pdf1,28 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.